← Back to Patent Explorer
US4347248A Expired / Lapsed US ⏱️ 0.0 years remaining

2,3-Disubstituted-thiazolo[3,2-a]pyrimidines

Assignee: Wyeth Holdings LLC
•
Filing: 1981-03-23
•
Granted: 1982-08-31
•
Expires: 2001-03-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract This disclosure describes 2,3-disubstituted-thiazolo[3,2-a]pyrimidines which are useful as diuretic agents.

Inventors

  • 👤 William B. Wright, Jr.
  • 👤 Andrew S. Tomcufcik
  • 👤 Joseph W. Marsico, Jr.

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 20:11
CPC Classifications
C; C07; C07D; C07D513/00; C07D513/02; C07D513/04; C07C; C07C45/00; C07C45/61; C07C45/67; C07C45/68; C07C45/72

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 16 words
A compound selected from the group consisting of 2-(p-fluorophenyl)-3-(p-fluorobenzyl)-6,7-dihydro-5H-thiazolo[3,2-a]pyrimidine and the pharmacologically acceptable acid-addition salts thereof.
Claim 2
Dependent Claim 16 words
A compound selected from the group consisting of 2-(p-fluorophenyl)-3-(p-fluorobenzyl)-6,7-dihydro-5H-thiazolo[3,2-a]pyrimidine and the pharmacologically acceptable acid-addition salts thereof.
Claim 3
Dependent Claim 16 words
A compound selected from the group consisting of 2-(o-fluorophenyl)-3-(p-methoxyphenyl)-6,7-dihydro-5H-thiazolo[3,2-a]pyrimidine and the pharmacologically acceptable acid-addition salts thereof.
Claim 4
Dependent Claim 16 words
A compound selected from the group consisting of 2-(o-fluorophenyl)-3-(p-methoxyphenyl)-6,7-dihydro-5H-thiazolo[3,2-a]pyrimidine and the pharmacologically acceptable acid-addition salts thereof.
Claim 5
Dependent Claim 16 words
A compound selected from the group consisting of 2-phenyl-3-benzyl-6,6-dimethyl-6,7-dihydro-5H-thiazolo[3,2-a]pyrimidine and the pharmacologically acceptable acid-addition salts thereof.
Claim 6
Dependent Claim 16 words
A compound selected from the group consisting of 2-phenyl-3-benzyl-6,6-dimethyl-6,7-dihydro-5H-thiazolo[3,2-a]pyrimidine and the pharmacologically acceptable acid-addition salts thereof.
Claim 7
Dependent Claim 16 words
A compound selected from the group consisting of 2-(p-fluorophenyl)-3-(p-fluorophenyl)-6,6-dimethyl-6,7-dihydro-5H-thiazolo[3,2-a]pyrimidine and the pharmacologically acceptable acid-addition salts thereof.
Claim 8
Dependent Claim 16 words
A compound selected from the group consisting of 2-(p-fluorophenyl)-3-(p-fluorophenyl)-6,6-dimethyl-6,7-dihydro-5H-thiazolo[3,2-a]pyrimidine and the pharmacologically acceptable acid-addition salts thereof.
Claim 9
Dependent Claim 16 words
A compound selected from the group consisting of 2-(p-bromophenyl)-3-(p-bromobenzyl)-6,6-dimethyl-6,7-dihydro-5H-thiazolo[3,2-a]pyrimidine and the pharmacologically acceptable acid-addition salts thereof.
Claim 10
Dependent Claim 16 words
A compound selected from the group consisting of 2-(p-bromophenyl)-3-(p-bromobenzyl)-6,6-dimethyl-6,7-dihydro-5H-thiazolo[3,2-a]pyrimidine and the pharmacologically acceptable acid-addition salts thereof.
Claim 11
Dependent Claim 15 words
A compound selected from the group consisting of 2-(p-tolyl)-3-(p-methylbenzyl)-6,6-dimethyl-6,7-dihydro-5H-thiazolo[3,2-a]pyrimidine and the pharmacologically acceptable salts thereof.
Claim 12
Dependent Claim 15 words
A compound selected from the group consisting of 2-(p-tolyl)-3-(p-methylbenzyl)-6,6-dimethyl-6,7-dihydro-5H-thiazolo[3,2-a]pyrimidine and the pharmacologically acceptable salts thereof.
Claim 13
Dependent Claim 15 words
A compound selected from the group consisting of 2-phenyl-3-(p-methoxyphenyl)-6,6-dimethyl-6,7-dihydro-5H-thiazolo[3,2-a]pyrimidine and the pharmacologically acceptable salts thereof.
Claim 14
Dependent Claim 15 words
A compound selected from the group consisting of 2-phenyl-3-(p-methoxyphenyl)-6,6-dimethyl-6,7-dihydro-5H-thiazolo[3,2-a]pyrimidine and the pharmacologically acceptable salts thereof.

References Cited (Backward Citations)

US3686173A Cited
US3671526A Cited
US4110451A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-08-30 1986-03-01 1986-08-31 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-08-30 1990-03-01 1990-08-31 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-08-30 1994-03-01 1994-08-31 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag